Multi-omics analysis identifies LANCL2 as a potential biomarker for the diagnosis and prognosis of gastric cancer
Abstract Gastric cancer (GC) constitutes a significant global public health burden due to its high morbidity rates and poor prognosis, underscoring the critical need for identifying novel therapeutic targets and elucidating their mechanisms. As a key member of the lanthionine synthetase C-like enzym...
Saved in:
| Main Authors: | Xidong Fang, Mengxiao Liu, Qian Ren, Renpeng Li, Guozhi Wu, Hao Yuan, Ya Zheng, Xi Gou, Yuping Wang, Yongning Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02745-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Thermal measurements support a role of the ABA/LANCL1−2 hormone/receptors system in thermogenesis
by: Giovanni Zocchi, et al.
Published: (2024-12-01) -
A multi-omics prognostic model of cuproptosis affects the prognosis of stomach adenocarcinoma
by: Yinying Wu, et al.
Published: (2025-06-01) -
Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer
by: Suyang Bai, et al.
Published: (2025-04-01) -
TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation
by: Hu X, et al.
Published: (2024-12-01) -
Correction: Identification and validation of monocyte to macrophage differentiation-associated as a prognostic biomarker in gastric cancer
by: Suyang Bai, et al.
Published: (2025-06-01)